A CatBoost machine learning model predicted reduced global longitudinal strain (<16%) from conventional echocardiographic measurements in cancer patients with an AUC of 0.748 and accuracy of 0.734.
Cross-Sectional (n=1,484)
No
Does a machine learning model using conventional echocardiographic measurements predict reduced global longitudinal strain (GLS < 16%) in cancer patients with preserved ejection fraction?
1,484 cancer patients who underwent echocardiography with GLS before or after anticancer chemotherapy, with LVEF ≥50% (patients with EF <50% excluded). Mean age 63.7 ± 13.3 years, 69% female. Single-center (Tokyo Metropolitan Tama Medical Center Hospital, Japan).
Machine learning models (specifically CatBoost classifier) using 24 conventional echocardiographic measurements and patient demographics (age, gender) to predict Low-GLS.
Direct measurement of Global Longitudinal Strain (GLS) via speckle-tracking echocardiography (reference standard).
Prediction of Low-GLS (defined as GLS < 16%) evaluated by area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, specificity, PPV, NPV, and F1 score.surrogate
Machine learning models using conventional echocardiographic parameters can moderately predict reduced global longitudinal strain (AUC 0.748) in cancer patients, potentially identifying those who would benefit most from direct GLS assessment.
Effect estimate: AUC 0.748
INTRODUCTION: Global longitudinal strain (GLS) is an important prognostic indicator for predicting heart failure and cancer therapy-related cardiac dysfunction (CTRCD). Although access to GLS measurement has increased across institutions, its actual use in clinical practice remains limited due to practical barriers such as limited time and insufficient training. If reduced GLS could be predicted from conventional echocardiographic parameters, it could help identify patients who would most benefit from direct GLS assessment. Therefore, in this study, we tested the hypothesis that reduced GLS can be predicted from conventional echocardiography via a machine learning (ML) approach. METHODS: This single-center cross-sectional study included patients who visited the Tokyo Metropolitan Tama Medical Center Hospital and underwent echocardiography with GLS before or after anticancer chemotherapy. Low-GLS was defined as a GLS < 16; otherwise, it was defined as Normal-GLS. Patients with EF < 50% were excluded. We developed ML models that predict Low-GLS from conventional echocardiography measurements. Sixteen ML models were constructed including various boosting and tree-based methods. We assessed the models by the area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, specificity, Positive predictive value (PPV), Negative predictive value (NPV), and F1 score. The Shapley Additive exPlanations (SHAP) method was employed to evaluate the essential predictors. RESULTS: A total of 1,484 patients (64 ± 13 years old, 69% female) were enrolled for ML model development, including 406 patients with Low-GLS and 1,078 with Normal-GLS. The best model for the test dataset was the CatBoost classifier (AUC, 0.748; accuracy, 0.734). Diastolic dysfunction indices such as septal/lateral mitral annular early diastolic velocity (e') and E-wave to atrial contraction filling velocity (E/A) and peak velocity‑related parameters aortic valve peak velocity (AV-Vmax) and left ventricular outflow tract velocity maximum (LVOT-Vmax) played essential roles in the Low-GLS prediction model. CONCLUSION: This study indicated the possibility that Low-GLS might be predicted by machine learning models from conventional echocardiography measurements in cancer patients.
Building similarity graph...
Analyzing shared references across papers
Loading...
Tagayasu Anzai
University of Hawaiʻi at Mānoa
Kenji Hirata
Hokkaido University
Ken Kato
University of Southern California
Cardio-Oncology
Hokkaido University
Hokkaido University Hospital
Sapporo University
Building similarity graph...
Analyzing shared references across papers
Loading...
Anzai et al. (Thu,) conducted a cross-sectional in Cancer (n=1,484). Machine learning models (CatBoost classifier) using conventional echocardiographic measurements was evaluated on Prediction of Low-GLS (< 16%) (AUC 0.748). A CatBoost machine learning model predicted reduced global longitudinal strain (<16%) from conventional echocardiographic measurements in cancer patients with an AUC of 0.748 and accuracy of 0.734.
synapsesocial.com/papers/6a1b7cac947c651ddaabf0cb — DOI: https://doi.org/10.1186/s40959-025-00348-z